Enoxaparin Sodium Injection
Product Images NDC 71839-113

Product Visual Gallery

This gallery contains 46 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 71839-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxafigurea (Enoxafigurea)

An instructional illustration showing hands holding a syringe and moving parts of it forward and backward, indicating an adjustment or priming step before injection. The illustration is related to the subcutaneous injection process, likely for enoxaparin sodium injection.*

FDA Label Image

Enoxafigureb (Enoxafigureb)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the skin of an arm. The syringe is held at an angle, and an arrow indicates the direction of injection.*

FDA Label Image

Enoxafigurec (Enoxafigurec)

An instructional illustration showing a hand administering a subcutaneous injection with a syringe into the upper arm of a person. The image emphasizes the injection technique using enoxaparin sodium injection.*

FDA Label Image

Enoxafigured (Enoxafigured)

An instructional illustration showing a hand holding a syringe, with an arrow indicating the direction to push the plunger. The syringe contains a clear liquid, suggesting preparation for a subcutaneous injection of enoxaparin sodium.*

FDA Label Image

Enoxafiguree (Enoxafiguree)

An instructional illustration showing a gloved hand disposing of a biohazard sharps container lid. The lid is marked with a red biohazard symbol and text. A downward arrow indicates the action of placing or securing the lid on the container, emphasizing safe disposal procedures for medical waste.*

FDA Label Image

Structure (Enoxastructuralformula)

Chemical structure of enoxaparin sodium showing repeating disaccharide units with associated substituents. The structure includes notations for variable groups (R1, R2), degree of polymerization (n), and relative proportions of components represented as percentages.*

FDA Label Image

Figure1 (Enoxafigure1)

A forest plot chart depicting relative risk comparisons between enoxaparin sodium and unfractionated heparin (UFH) across multiple patient subgroups, including sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI within 30 days. The chart shows relative risk estimates with confidence intervals and percentages for UFH and enoxaparin, indicating risk reduction favoring enoxaparin in most subgroups.*

FDA Label Image

Figure2 (Enoxafigure2)

A survival analysis plot showing the hazard distribution function comparing enoxaparin sodium and unfractionated heparin (UFH) over time in days to death or myocardial re-infarction. The main graph covers 0 to 30 days, with enoxaparin exhibiting a lower hazard than UFH. An inset graph displays the hazard function up to one year, highlighting statistical significance in differences via log-rank tests (p<0.0001 and p=0.0111). Number at risk counts are listed below the axes.*

FDA Label Image

Enoxinstuse1 (Enoxinstuse1)

An instructional diagram depicting a syringe before and after use. Before use, the syringe is shown with the plunger rod, needle, and needle cap labeled. After use, the syringe is shown with the plunger rod depressed and a protective sleeve covering the needle, indicating a safety mechanism engaged.*

FDA Label Image

Structure (Enoxinstuse2)

An instructional diagram showing components for enoxaparin sodium injection administration. It includes a prefilled syringe labeled as enoxaparin sodium, a cotton ball or gauze, an alcohol wipe, a small adhesive bandage, and a sharps disposal container. Each item is clearly labeled and drawn in simple black and white line art.*

FDA Label Image

Enoxinstuse3 (Enoxinstuse3)

Illustration showing two hands preparing a prefilled syringe injection. One hand is peeling back a protective adhesive strip, while the other holds the syringe, depicting the initial steps to prepare a subcutaneous injection, consistent with an enoxaparin sodium injection product.*

FDA Label Image

Enoxinstuse4 (Enoxinstuse4)

Syringe injection device for enoxaparin sodium, a subcutaneous injection. The syringe features a black plunger and a visible medication chamber with measurement markings. The image includes a label area indicating an expiration date. This product is labeled by BE Pharmaceuticals Inc.*

FDA Label Image

Enoxinstuse5 (Enoxinstuse5)

Illustration of a syringe filled with a clear liquid, showing the interior components including the plunger, barrel, and needle cover. The liquid is labeled as "Clear Liquid." The image depicts the syringe in a horizontal orientation with detailed shading to highlight its parts.*

FDA Label Image

Enoxinstuse6 (Enoxinstuse6)

An illustration showing the front torso of a human body with two gray shaded rectangles on the lower abdominal area, indicating possible injection sites for subcutaneous administration.*

FDA Label Image

Enoxinstuse7 (Enoxinstuse7)

Illustration showing a hand applying a small adhesive patch or injection site on the lower abdomen, demonstrating a step in the subcutaneous injection process for enoxaparin sodium injection.*

FDA Label Image

Enoxinstuse8 (Enoxinstuse8)

An instructional illustration showing two hands preparing an injection. One hand holds a small vial or cartridge, while the other hand holds a syringe with a needle, poised to connect or draw medication from the vial. Arrows indicate the direction for aligning or attaching the two components.*

FDA Label Image

Enoxinstuse9 (Enoxinstuse9)

An instructional illustration showing a hand adjusting the dose on a syringe. The syringe is marked with a measurement scale, and a downward arrow indicates the action of setting the dose. The text "Set your dose" is displayed next to the syringe.*

FDA Label Image

Enoxinstuse10 (Enoxinstuse10)

An instructional illustration showing a hand pinching the skin on the side of a person's abdomen, suggesting preparation for a subcutaneous injection.*

FDA Label Image

Enoxinstuse11 (Enoxinstuse11)

An instructional illustration showing a hand holding a syringe angled at 90 degrees to the skin, indicating proper technique for a subcutaneous injection, consistent with the route of administration for enoxaparin sodium injection.*

FDA Label Image

Enoxinstuse12 (Enoxinstuse12)

Illustration showing the administration of a subcutaneous injection in the abdominal area using a syringe. The image depicts one hand pinching the skin while the other hand inserts the needle at an angle, with an arrow indicating the injection direction.*

FDA Label Image

Enoxinstuse13 (Enoxinstuse13)

An instructional illustration showing a hand holding a syringe for subcutaneous injection. The image depicts the syringe positioned near the abdomen, indicating the injection site and technique for administering enoxaparin sodium subcutaneously.*

FDA Label Image

Enoxinstuse14 (Enoxinstuse14)

An instructional illustration showing a hand holding a syringe with a protective sleeve. An arrow labeled 'CLICK' indicates pressing the cap to activate or remove the protective sleeve on the syringe, likely part of the enoxaparin sodium injection device.*

FDA Label Image

Structure (Enoxinstuse15)

An instructional diagram showing a hand disposing of an enoxaparin sodium syringe by placing its needle cap into a labeled sharps disposal container. The image is labeled to identify the 'Enoxaparin Sodium Syringe' and the 'Needle Cap.'*

FDA Label Image

Enoxinstuse-belogo (Enoxinstuse Belogo)

FDA Label Image

Enoxabe (Enoxabe)

FDA Label Image

Pfs Label (Enoxa30mgpfslabel)

Label for Enoxaparin Sodium Injection USP, 30 mg/0.3 mL, Rx Only. The label shows the NDC 71839-109-10 and states the manufacturer as Biological E. Limited. It includes placeholders for lot number and expiration date and features a small barcode.*

FDA Label Image

Pfs Label (Enoxa40mgpfslabel)

Label for Enoxaparin Sodium Injection, USP 40 mg/0.4 mL, a subcutaneous injection. The label shows the NDC number 71839-110-10, manufacturer Biological E. Limited, and includes spaces for lot number and expiration date. The label is marked Rx Only.*

FDA Label Image

Pfs Label (Enoxa60mgpfslabel)

Label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL, a prescription subcutaneous injection. The label includes the NDC 71839-111-10, manufacturer listed as Biological E. Limited, and spaces for lot and expiration dates.*

FDA Label Image

Pfs Label (Enoxa80mgpfslabel)

Label for Enoxaparin Sodium Injection, USP, 80 mg/0.8 mL, a prescription drug. The label shows the NDC 71839-112-10 and indicates it is manufactured by Biological E. Limited. It includes space for lot and expiration dates and features barcodes on the right side.*

FDA Label Image

Pfs Label (Enoxa100mgpfslabel)

Label for Enoxaparin Sodium Injection USP 100 mg/mL by Biological E. Limited. The label includes prescription status (Rx Only), NDC 71839-113-10, and spaces for lot number and expiration date.*

FDA Label Image

Pfs Label (Enoxa120mgpfslabel)

Label for Enoxaparin Sodium Injection, USP, 120 mg/0.8 mL. The label includes the NDC number 71839-115-10 and states the manufacturer as Biological E. Limited. It also features a barcode and space for lot and expiration date information. The injection is for prescription use only.*

FDA Label Image

Pfs Label (Enoxa150mgpfslabel)

Label for Enoxaparin Sodium Injection, USP 150 mg/mL, an injectable medication for subcutaneous use. The label includes the NDC 71839-116-10, manufacturer Biological E. Limited, and space for lot number and expiration date. It is marked Rx Only.*

FDA Label Image

Blister-30mg (Blister 30mg)

Enoxaparin Sodium Injection, USP 30 mg/0.3 mL single dose syringes with automatic safety device. The label shows two identical panels for 0.3 mL syringes intended for subcutaneous injection, manufactured by BE Pharmaceuticals Inc., with NDC 71839-109-10. Includes storage instructions, warnings, batch coding area, and barcode.*

FDA Label Image

Blister-40mg (Blister 40mg)

Label for enoxaparin sodium injection, USP, 40 mg/0.4 mL in a single-dose syringe with automatic safety device. The label states the route as subcutaneous injection and specifies a 0.4 mL syringe volume. Distributed by BE Pharmaceuticals Inc. The label includes storage instructions, a barcode, and batch information area.*

FDA Label Image

Blister-60mg (Blister 60mg)

Packaging label for Enoxaparin Sodium Injection, USP, 60 mg/0.6 mL, by BE Pharmaceuticals Inc. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection, each syringe containing 60 mg of enoxaparin sodium per 0.6 mL. The label includes dosage, storage instructions, and barcode information.*

FDA Label Image

Blister-80mg (Blister 80mg)

Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL, single-dose syringe with automatic safety device. The label states the dosage form as a 0.8 mL syringe for subcutaneous injection. Distributed by BE Pharmaceuticals Inc., the label includes storage instructions, barcode, lot number, and expiration date areas.*

FDA Label Image

Blister-100mg (Blister 100mg)

Label for enoxaparin sodium injection, USP, 100 mg/mL in a single-dose 1 mL syringe for subcutaneous injection. The label shows product name, strength, dosage form, route, and that it includes an automatic safety device. It includes storage instructions, manufacturer BE Pharmaceuticals Inc., barcode, and batch and expiration date areas.*

FDA Label Image

Blister-120mg (Blister 120mg)

Label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL single-dose syringes by BE Pharmaceuticals Inc. The label indicates subcutaneous injection with an automatic safety device. It includes product storage instructions, warnings, NDC codes 71839-115-10 and 71839-115-15, lot number, expiration date, and barcode.*

FDA Label Image

Blister-150mg (Blister 150mg)

Packaging label for Enoxaparin Sodium Injection USP, 150 mg/1 mL, single-dose syringes with automatic safety device. The label specifies the product is for subcutaneous injection, with each box containing one 1 mL syringe. The labeler is BE Pharmaceuticals Inc., and storage instructions and warnings are included along with the NDC 71839-116-10 barcode.*

FDA Label Image

Carton-30mg (Carton 30mg)

Packaging label for Enoxaparin Sodium Injection, USP 30 mg/0.3 mL by BE Pharmaceuticals Inc. The box contains single-dose syringes with an automatic safety device for subcutaneous injection. The label includes directions for use, storage instructions, barcode, NDC numbers 71839-109-10 and 71839-109-10, and a note that the product is Rx only. The package contains ten 0.3 mL syringes.*

FDA Label Image

Carton-40mg (Carton 40mg)

Packaging label for Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, a subcutaneous injection. The label includes directions for use with a single dose syringe and automatic safety device. It is marked Rx Only and indicates a package containing ten 0.4 mL syringes. The labeler is BE Pharmaceuticals Inc.*

FDA Label Image

Carton-60mg (Carton 60mg)

Packaging label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL by BE Pharmaceuticals Inc. The label indicates it is for subcutaneous injection, with single-dose syringes containing 0.6 mL. It includes usage instructions for the automatic safety device and storage information, with orange and white color highlights and a barcode.*

FDA Label Image

Carton-80mg (Carton 80mg)

Packaging label for Enoxaparin Sodium Injection, USP 80 mg/0.8 mL by BE Pharmaceuticals Inc. The label indicates single-dose syringes with automatic safety device for subcutaneous injection, with ten 0.8 mL syringes per box. The label includes usage directions, storage instructions, and a barcode.*

FDA Label Image

Carton-100mg (Carton 100mg)

Packaging label for Enoxaparin Sodium Injection, USP 100 mg/mL by BE Pharmaceuticals Inc. The label indicates single-dose syringes with automatic safety device for subcutaneous injection, containing ten 1 mL syringes. It includes dosage instructions illustrated in diagrams, storage conditions, warnings, barcode, and manufacturing site information (Made in India).*

FDA Label Image

Carton-120mg (Carton 120mg)

Packaging label for Enoxaparin Sodium Injection, USP 120 mg/0.8 mL, subcutaneous injection by BE Pharmaceuticals Inc. The label shows the product name, strength, dosage form, quantity (ten 0.8 mL syringes), and Rx only status. It includes directions for use with an automatic safety device, storage instructions, barcode, and manufacturer details. The label uses a purple and white color scheme with black text.*

FDA Label Image

Carton-150mg (Carton 150mg)

Box packaging label for Enoxaparin Sodium Injection, USP, 150 mg/mL by BE Pharmaceuticals Inc. The label indicates it is a single-dose syringe with an automatic safety device for subcutaneous injection. The box contains ten 1 mL syringes and includes directions for use and storage instructions. A barcode and lot information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.